Halozyme stock rises after winning injunction against Merck
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 124.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.54 | 52 Week High | $18.39 | |||
| Open | $124.54 | 52 Week Low | $6.96 | |||
| Day High | $124.54 | P/E | N/A | |||
| Day Low | $124.54 | EPS | $-0.58 | |||
| Volume | 735 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 147.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.24 | 52 Week High | $65.46 | |||
| Open | $147.24 | 52 Week Low | $47.97 | |||
| Day High | $147.24 | P/E | 100.16 | |||
| Day Low | $147.24 | EPS | $1.47 | |||
| Volume | 144,257 | |||||
